Recombinant ASFV I177L Protein, N-His

Introduction

The recombinant ASFV I177L protein is a viral protein that has been genetically engineered for use in various research and diagnostic applications. It is a highly specific and sensitive antigen that has been shown to have potential in the development of new vaccines and diagnostic tools for African swine fever virus (ASFV).

Structure of Recombinant ASFV I177L Protein

The recombinant ASFV I177L protein is a 177 amino acid protein that is derived from the I177L gene of the ASFV genome. It is a structural protein that is found on the surface of the virus and is responsible for viral attachment and entry into host cells. The recombinant protein is produced using molecular cloning techniques, where the I177L gene is inserted into a suitable expression vector and then expressed in a host cell such as E. coli or insect cells.

The recombinant protein is then purified and can be used in a variety of applications due to its high purity and specificity. It is important to note that the recombinant ASFV I177L protein is not infectious and does not pose a risk to human or animal health.

Activity of Recombinant ASFV I177L Protein

The recombinant ASFV I177L protein is a highly active protein that has been shown to have a strong binding affinity for ASFV. It is able to specifically recognize and bind to the virus, making it a valuable tool in the development of diagnostic tests. The protein is also able to induce a strong immune response in animals, making it a potential candidate for use in vaccine development.

Additionally, the recombinant protein has been shown to have potential in the development of novel antiviral therapies. It has been found to interfere with viral entry and replication, making it a promising target for the development of drugs to combat ASFV infections.

Application of Recombinant ASFV I177L Protein

The recombinant ASFV I177L protein has a wide range of applications in both research and diagnostic settings. Some of the key applications include:

Vaccine Development

The recombinant protein has been identified as a potential candidate for use in the development of a vaccine against ASFV. Its ability to induce a strong immune response and its specificity for the virus make it a promising component of a multi-component vaccine.

Diagnostic Tests

The recombinant protein can be used in various diagnostic tests for the detection of ASFV. These include enzyme-linked immunosorbent assays (ELISAs), lateral flow assays, and immunofluorescence assays. Its high specificity and sensitivity make it a valuable tool for the accurate and early detection of ASFV infections.

Antiviral Therapy

The recombinant ASFV I177L protein has potential as a target for the development of antiviral drugs. Its ability to interfere with viral entry and replication makes it a promising candidate for the development of novel therapeutics to combat ASFV infections.

Research Tool

The recombinant protein can also be used as a research tool to study the structure and function of ASFV. Its high purity and specificity make it a valuable tool for studying the virus and its interactions with host cells.

Conclusion

The recombinant ASFV I177L protein is a highly specific and sensitive antigen that has a wide range of applications in the field of ASFV research and diagnostics. Its potential as a vaccine candidate and target for antiviral therapy make it a valuable tool in the fight against this devastating virus. With ongoing research and development, the recombinant protein has the potential to contribute significantly to the control and prevention of ASFV outbreaks.